Canopy Growth, once an early publicly traded cannabis company, remains a penny stock despite a strategic recapitalization and the all-stock acquisition of MTL Cannabis that greatly increased share count. Fiscal 2027 Q1 showed 13% revenue growth, improved gross margins and a 68% smaller net loss, but dilution and sector risks persist. Most investors should monitor rather than buy, unless extremely aggressive.
